Economic evaluation of enzalutamide and androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer in the United Kingdom

Additional Metadata
Keywords	Cost-effectiviness; health technology assessment; enzalutamide; anti-androgens;Prostate cancer; hormone-sensitive; metastatic disease;QoL; utility
Thesis Advisor	Holleman, M.S.
Persistent URL	hdl.handle.net/2105/62477
Series	Master Health Economics, Policy and Law
Organisation	Erasmus School of Health Policy & Management
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Tarrahi, F.Z. (2021). Economic evaluation of enzalutamide and androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer in the United Kingdom. In Master Health Economics, Policy and Law.http://hdl.handle.net/2105/62477

Publication